Several other research analysts have also recently commented on the stock. Commerzbank set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a neutral rating in a research report on Wednesday, March 28th. HSBC set a €67.00 ($82.72) price target on shares of Gerresheimer and gave the stock a neutral rating in a research note on Monday, March 26th. JPMorgan Chase set a €74.00 ($91.36) price target on shares of Gerresheimer and gave the stock a neutral rating in a research note on Tuesday, March 20th. Kepler Capital Markets set a €65.00 ($80.25) price target on shares of Gerresheimer and gave the stock a sell rating in a research note on Friday, March 16th. Finally, Berenberg Bank set a €78.00 ($96.30) price target on shares of Gerresheimer and gave the stock a buy rating in a research note on Friday, March 9th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of €68.67 ($84.77).
ETR GXI opened at €66.45 ($82.04) on Thursday. Gerresheimer has a 52 week low of €59.97 ($74.04) and a 52 week high of €78.25 ($96.60).
TRADEMARK VIOLATION WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3342293/gerresheimer-gxi-receives-neutral-rating-from-deutsche-bank.html.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.